By Jennifer Rigby LONDON (Reuters) –     A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start deliveries of Gilead Sciences’ lenacapavir on that timeline, said Hui Yang, head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria. However, she said a lot of things need to happen first, i…

WTVB

New HIV prevention drug could reach poorest countries by 2025, says health official

Gilead Sciences is seeking approval from the USFDA and the World Health Organization (WHO) for a global rollout of its injectable drug version.

All Sides

Media Bias/Fact Check

Hindustan Times

HT Media

New Delhi

Delhi

India

New injectable variant of HIV-preventing drug in ‘poorest’ countries soon, claims health official

LONDON (Reuters) -     A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. Read full story

The Star Kuala Lumpur

Star Media Group

Malaysia

LONDON - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.

The Straits Times

Singapore Press Holdings

Singapore

Specialists from the State Scientific Center “Vector” of Rospotrebnadzor have already calculated the structure of the HIV vaccine, Alexander Agafonov, General Director of the Center, said in an interview with RIA Novosti. RIA Novosti, 18.12.2024

Специалисты ГНЦ "Вектор" Роспотребнадзора уже рассчитали структуру вакцины от ВИЧ, заявил в интервью РИА Новости генеральный директор центра Александр Агафонов. РИА Новости, 18.12.2024

В "Векторе" рассказали о работе над вакциной от ВИЧ

RIA Novosti [🇷🇺-affiliated]

Government of Russia

Russia

Vector talked about working on an HIV vaccine

Midwest Communications

Lenacapavir, a drug against HIV, promises simplified and effective prevention even if its price is still high. But thanks to licenses, it should be available cheaply in 120 countries.

Le lenacapavir, un médicament contre le VIH, promet une prévention simplifiée et efficace même si son prix reste encore élevé. Mais grâce à des licences, il devrait être accessible à bas prix dans 120 pays

Le lenacapavir, un médicament qui pourrait changer la lutte contre le VIH

20 Minutes

France

Lenacapavir, a drug that could change the fight against HIV

A new HIV-prolonged preventive drug could reach the world's poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.The goal is to start supplying Gilead Sciences' lenacapavir within that time frame, according to Hui Yang, who is responsible for Global Fund to Fight AIDS, Tuberculosis and Malaria supply operations.

Un nuevo medicamento preventivo de acción prolongada contra el VIH podría llegar a los países más pobres del mundo a finales de 2025 o principios de 2026, dijo el martes a Reuters un funcionario de salud mundial.El objetivo es empezar a suministrar lenacapavir de Gilead Sciences en ese plazo, según Hui Yang, responsable de operaciones de suministro del Fondo Mundial de Lucha contra el Sida, la Tuberculosis y la Malaria.Te puede interesarGeopolít…

Nuevo medicamento para prevenir el VIH podría llegar a los países más pobres en 2025: responsable sanitario

El Economista

New HIV prevention drug could reach the poorest countries by 2025: Health Officer

Lenacapavir is a new HIV injectable drug that promises to revolutionize the fight against this disease, could reach the poorest countries by 2025. It is a new HIV-prolonged preventive drug that could reach the poorest countries in the world by the end of the next year or early in 2026, as revealed to Reuters, Hui Yang, a global health official. Global Hope: Lenacapavir, HIV-injection, promises to help millions by 2025. The goal is to start suppl…

El Lenacapavir es un nuevo medicamento inyectable contra el VIH que promete revolucionar la lucha contra esta enfermedad, podría llegar a los países más pobres en 2025. Se trata de un nuevo medicamento preventivo de acción prolongada  contra el VIH  que podría llegar a los países más pobres del mundo para finales del siguiente año o a principios de 2026, según reveló a Reuters, Hui Yang, un funcionario de salud mundial.  
Esperanza global: Lenac…

Esperanza para millones: Lenacapavir, el medicamento inyectable contra el VIH llega en 2025

TV Azteca

Grupo Salinas

Hope for Millions: Lenacapavir, the HIV injectable medicine arrives in 2025

A new drug for preventing HIV could be distributed in poor countries next year.

Un medicament nou pentru prevenirea HIV ar putea fi distribuit anul viitor în ţările sărace.

Un medicament nou pentru prevenirea HIV ar putea fi distribuit anul viitor în ţările sărace

Mediafax

A new HIV prevention drug could be distributed to poor countries next year

By Jennifer Rigby LONDON (Reuters) – A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start deliveries of Gilead Sciences’ lenacapavir on that timeline, said Hui Yang, head of supply operations at […]

New HIV prevention drug could reach poorest countries by 2025, says health official

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics